Sarbagili-Shabat, C.; Albenberg, L.; Van Limbergen, J.; Pressman, N.; Otley, A.; Yaakov, M.; Wine, E.; Weiner, D.; Levine, A.
A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study. Nutrients 2021, 13, 3736.
https://doi.org/10.3390/nu13113736
AMA Style
Sarbagili-Shabat C, Albenberg L, Van Limbergen J, Pressman N, Otley A, Yaakov M, Wine E, Weiner D, Levine A.
A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study. Nutrients. 2021; 13(11):3736.
https://doi.org/10.3390/nu13113736
Chicago/Turabian Style
Sarbagili-Shabat, Chen, Lindsey Albenberg, Johan Van Limbergen, Naomi Pressman, Anthony Otley, Michal Yaakov, Eytan Wine, Dror Weiner, and Arie Levine.
2021. "A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study" Nutrients 13, no. 11: 3736.
https://doi.org/10.3390/nu13113736
APA Style
Sarbagili-Shabat, C., Albenberg, L., Van Limbergen, J., Pressman, N., Otley, A., Yaakov, M., Wine, E., Weiner, D., & Levine, A.
(2021). A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study. Nutrients, 13(11), 3736.
https://doi.org/10.3390/nu13113736